- Is this scientifically feasible?
In layman's terms, Antibodies kill the cause of infections and can kill a pathogen on contact in most environments. Several Infectious Disease specialists agree this could be a viable solution. - Is it safe?
Our Antibodies are harvested from eggs, which are Generally Regarded As Safe (GRAS) by the FDA. - Will it work?
We have proven oral dose Antibodies are effective, with two registered Veterinary Biologic treatments for animals and an ongoing phase 2 clinical trial of our C Difficile Antibodies for humans. Research published 10/27/21 has shown the viability of the technique in vitro (Egg yolk immunoglobulin (IgY) targeting SARS-CoV-2 S1 as potential virus entry blocker). - Can it be produced in volume?
Egg derived Antibodies are the easiest to scale up of all Antibody sources. Rose Acre Farms, North America's largest family owned and the World's fourth largest egg producer has already agreed to work with us. The United Egg Producers are also onside (see References tab). - Will it be affordable?
Egg derived Antibodies are the least costly Antibodies to produce. - Can it be done quickly?
We need a vaccine to start the process, which we can do much faster than a human vaccine. After that the first product can be available within 4 months. - Can it be used for future pandemics?
Once the platform is shown to work it's a simple matter to change the target. And that target may also eventually include the yearly flu virus. - Would people take the treatment?
Our treatment will provide a scientifically proven solution, which could be used as a stand alone or in conjunction with traditional vaccine therapy .
The following video was produced during COVID 19 lockdowns. It outlines our oral antibody solution.